Sign in
Download Opera News App

DISEASE PREVENTION AND TREATMENT

Olatec Therapeutics’ Lead Compound, Dapansutrile, a Selective NLRP3 Inhibitor, Prevents the Inflammatory Response and Restores Cognitive and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease

Olatec Therapeutics’ Lead Compound, Dapansutrile, a Selective NLRP3 Inhibitor, Prevents the Inflammatory Response and Restores Cognitive and Behavioral Deficits in a Mouse Model of Alzheimer’s Disease

Olatec Therapeutics LLC (“Olatec”) today announced the publication of data demonstrating the benefits of its selective NLRP3 inhibitor, dapansutrile, in a mouse model of Alzheimer’s Disease (AD). The data are published in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). The study shows...

Read Full Story
Charles A. Dinarello Dapansutrile Martin Korte NLRP3 Niklas Lonnemann Olatec

Top News

US POLITICS

8 Democrats defect on $15 minimum wage hike

politico.com
8 Democrats defect on $15 minimum wage hike

US POLITICS

8 Democrats defect on $15 minimum wage hike

politico.com

US POLITICS

Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

foxnews.com
Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

US POLITICS

Cuomo aide implicated in nursing home coverup taught 'ethics in government' class

foxnews.com

Comments

Load app to read more comments